These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 9663206)

  • 1. Induction of prostate-specific antigen expression by synthetic progestins in patients with prostate and breast cancer.
    Diamandis EP
    Mayo Clin Proc; 1998 Jul; 73(7):706-7. PubMed ID: 9663206
    [No Abstract]   [Full Text] [Related]  

  • 2. Prostate-specific antigen response to withdrawal of megestrol acetate in a patient with hormone-refractory prostate cancer.
    Wehbe TW; Stein BS; Akerley WL
    Mayo Clin Proc; 1997 Oct; 72(10):932-4. PubMed ID: 9379696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progestin regulation of vascular endothelial growth factor in human breast cancer cells.
    Hyder SM; Murthy L; Stancel GM
    Cancer Res; 1998 Feb; 58(3):392-5. PubMed ID: 9458078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of prostate-specific antigen gene expression by an LH-RH analogue in human prostatic cells.
    Sica G; Zelano G; Settesoldi D; Iacopino F
    Anticancer Res; 2003; 23(2B):1283-7. PubMed ID: 12820384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostate-specific antigen decline after withdrawal of low-dose megestrol acetate.
    Burch PA; Loprinzi CL
    J Clin Oncol; 1999 Mar; 17(3):1087-8. PubMed ID: 10071307
    [No Abstract]   [Full Text] [Related]  

  • 6. Regulation of thrombospondin-1 by natural and synthetic progestins in human breast cancer cells.
    Hyder SM; Liang Y; Wu J; Welbern V
    Endocr Relat Cancer; 2009 Sep; 16(3):809-17. PubMed ID: 19570906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of somatostatin analogs in the management of prostate cancer.
    Sinisi AA; Rossi V; Prezioso D; Notaro A; Bellastella G; Panza N; Bellastella A; Pasquali D
    J Endocrinol Invest; 2003; 26(8 Suppl):120-4. PubMed ID: 15233227
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of leuprorelin acetate on cell growth and prostate-specific antigen gene expression in human prostatic cancer cells.
    Sica G; Iacopino F; Settesoldi D; Zelano G
    Eur Urol; 1999; 35 Suppl 1():2-8. PubMed ID: 10081696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Evaluation of megestrol acetate as monotherapy in disseminated prostatic carcinoma].
    Gallo Rolania FJ
    Arch Esp Urol; 1998 Mar; 51(2):151-3. PubMed ID: 9586312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Down-Regulation of prostate-specific antigen expression by ligands for peroxisome proliferator-activated receptor gamma in human prostate cancer.
    Hisatake JI; Ikezoe T; Carey M; Holden S; Tomoyasu S; Koeffler HP
    Cancer Res; 2000 Oct; 60(19):5494-8. PubMed ID: 11034093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The anti-proliferative effects of 1alpha,25(OH)2D3 on breast and prostate cancer cells are associated with induction of BRCA1 gene expression.
    Campbell MJ; Gombart AF; Kwok SH; Park S; Koeffler HP
    Oncogene; 2000 Oct; 19(44):5091-7. PubMed ID: 11042697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of progestin treatment on estradiol-and growth factor-stimulated breast cancer cell lines.
    Cappelletti V; Miodini P; Fioravanti L; Di Fronzo G
    Anticancer Res; 1995; 15(6B):2551-5. PubMed ID: 8669822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The estrogenic activity of synthetic progestins used in oral contraceptives enhances fatty acid synthase-dependent breast cancer cell proliferation and survival.
    Menendez JA; Oza BP; Colomer R; Lupu R
    Int J Oncol; 2005 Jun; 26(6):1507-15. PubMed ID: 15870863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Change of the cell cycle after flutamide treatment in prostate cancer cells and its molecular mechanism.
    Wang Y; Shao C; Shi CH; Zhang L; Yue HH; Wang PF; Yang B; Zhang YT; Liu F; Qin WJ; Wang H; Shao GX
    Asian J Androl; 2005 Dec; 7(4):375-80. PubMed ID: 16281084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dramatic prostate specific antigen decrease in response to discontinuation of megestrol acetate in advanced prostate cancer: expansion of the antiandrogen withdrawal syndrome.
    Dawson NA; McLeod DG
    J Urol; 1995 Jun; 153(6):1946-7. PubMed ID: 7538601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progestins regulate genes that can elicit both proliferative and antiproliferative effects in breast cancer cells.
    Purmonen S; Manninen T; Pennanen P; Ylikomi T
    Oncol Rep; 2008 Jun; 19(6):1627-34. PubMed ID: 18497975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Megestrol acetate as hormone therapy in oncology].
    Berstein LM
    Vopr Onkol; 1998; 44(2):142-8. PubMed ID: 9615815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting amino acid transport in metastatic castration-resistant prostate cancer: effects on cell cycle, cell growth, and tumor development.
    Wang Q; Tiffen J; Bailey CG; Lehman ML; Ritchie W; Fazli L; Metierre C; Feng YJ; Li E; Gleave M; Buchanan G; Nelson CC; Rasko JE; Holst J
    J Natl Cancer Inst; 2013 Oct; 105(19):1463-73. PubMed ID: 24052624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-6 regulates prostate-specific protein expression in prostate carcinoma cells by activation of the androgen receptor.
    Hobisch A; Eder IE; Putz T; Horninger W; Bartsch G; Klocker H; Culig Z
    Cancer Res; 1998 Oct; 58(20):4640-5. PubMed ID: 9788616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiac glycosides decrease prostate specific antigen expression by down-regulation of prostate derived Ets factor.
    Juang HH; Lin YF; Chang PL; Tsui KH
    J Urol; 2010 Nov; 184(5):2158-64. PubMed ID: 20850842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.